A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings ...

In an era marked by remarkable advancements in medical diagnostics, the global minimal residual disease (MRD) testing market is poised for unprecedented growth. Projections suggest that by 2031, the ...

Europe’s minimal residual disease (MRD) testing market has witnessed remarkable growth, underscoring its pivotal role in healthcare diagnostics. Valued at $265.6 million in 2021, this market is poised ...

B cells are a subtype of lymphocyte. They form part of the adaptive immune response and mediate humoral immunity. B cells can produce high-affinity antibodies and generate immunological memory.

Cartron et al. report the results of a phase 2 trial of the CD20–CD3 T cell-engaging bispecific antibody glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing chimeric ...

Apr. 4, 2025 — A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated ...